Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02910583 |
|---|---|
| Brief Title: | Ibrutinib Plus Venetoclax in Subjects With Treatment-naive Chronic Lymphocytic Leukemia /Small Lymphocytic Lymphoma (CLL/SLL) (Captivate) |
| First Submitted : | September 20, 2016 |
| First Submitted that Met QC Criteria : | September 20, 2016 |
| First Posted : | September 22, 2016 (Estimate) |
| Results First Submitted : | November 9, 2021 |
| Results First Submitted that Met QC Criteria : | January 27, 2022 |
| Results First Posted : | February 18, 2022 |
| Last Update Submitted that Met QC Criteria : | April 1, 2024 |
| Last Update Posted : | April 3, 2024 |